Wealth Watch Advisors’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History

Wealth Watch Advisors’s Portfolio SBIO Stock Details SBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-50	Closed	-$2.56K	–	726
2025 Q4	$2.56K	Buy	+50	New	+$2.31K	﹤0.01%	630

Other funds holding SBIO

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

CIS

Connors Investor Services Wyomissing, Pennsylvania $1.16B AUM 27.24% 1-Year Est. Return

GAM

Griffin Asset Management New York $949M AUM 24.98% 1-Year Est. Return

MWM

Moran Wealth Management Naples, Florida $3.67B AUM 36.71% 1-Year Est. Return

Wealth Watch Advisors's SBIO Position: Q1 2026 in Review

Wealth Watch Advisors sold out of ALPS Medical Breakthroughs ETF (SBIO) in Q1 2026, closing a stake of 50 shares — an estimated $2.56K sold.

Wealth Watch Advisors first reported a position in SBIO in Q4 2025 and held it in 1 quarter. The position peaked at $2.56K in Q4 2025. 60 funds tracked by Wall St. Rank hold SBIO as of Q1 2026.

Wealth Watch Advisors reported no remaining ALPS Medical Breakthroughs ETF position as of Q1 2026 after selling out during the quarter.
Wealth Watch Advisors sold 50 ALPS Medical Breakthroughs ETF shares in Q1 2026, an estimated $2.56K.
Wealth Watch Advisors first reported a position in ALPS Medical Breakthroughs ETF in Q4 2025 and held it in 1 quarter.
Wealth Watch Advisors's ALPS Medical Breakthroughs ETF position peaked at $2.56K in Q4 2025.
60 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q1 2026.

Based on Wealth Watch Advisors's 13F filing for Q1 2026, filed 15 May 2026.